secwatch.observer — SEC 8-K summary
======================================

Issuer:     Aligos Therapeutics, Inc. (ALGS)
CIK:        0001799448
Form:       8-K
Filed at:   2024-06-28T23:59:59+00:00
Accession:  0001193125-24-172218
Event type: other_material
Sentiment:  neutral
Materiality: 0.35
Item codes: 5.02, 5.07, 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Aligos stockholders approve increase in authorized shares from 300M to 500M and amendment to 2020 incentive plan
--------------------------------------------------------------------------------

- Stockholders approved increase in authorized shares from 300M to 500M, effective June 27, 2024.
- Approved amendment to 2020 incentive plan to treat pre-funded warrants with exercise price ≤ $0.01 as common stock for annual share increases.
- Board authorized to effect reverse stock split if deemed in best interests; no immediate action.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1799448/000119312524172218/0001193125-24-172218-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1799448/000119312524172218/d129014d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-172218

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer